Susquehanna International Group, LLP Evolus, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$10.45 - $13.76 $497,419 - $654,976	-47,600 Reduced 21.84%	170,300 $1.85 Million
Q1 2024 May 07, 2024	BUY	$9.99 - $14.91 $1.29 Million - $1.93 Million	129,300 Added 145.94%	217,900 $3.05 Million
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $68,400 - $94,770	9,000 Added 11.31%	88,600 $932,000
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $296,010 - $422,279	41,400 Added 108.38%	79,600 $727,000
Q2 2023 Aug 11, 2023	BUY	$7.23 - $10.52 $174,966 - $254,584	24,200 Added 172.86%	38,200 $277,000
Q1 2023 May 16, 2023	SELL	$7.81 - $11.05 $400,653 - $566,865	-51,300 Reduced 78.56%	14,000 $118,000
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $200,816 - $275,660	-30,800 Reduced 32.05%	65,300 $490,000
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $239,008 - $422,576	-30,800 Reduced 24.27%	96,100 $774,000
Q2 2022 Aug 15, 2022	SELL	$10.22 - $13.94 $680,652 - $928,404	-66,600 Reduced 34.42%	126,900 $1.47 Million
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $641,016 - $1.45 Million	122,800 Added 173.69%	193,500 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $96,660 - $150,840	-18,000 Reduced 20.29%	70,700 $460,000
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $629,280 - $1.17 Million	-85,500 Reduced 49.08%	88,700 $676,000
Q2 2021 Aug 11, 2021	SELL	$8.42 - $13.96 $1.04 Million - $1.72 Million	-123,400 Reduced 41.47%	174,200 $2.2 Million
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $839,360 - $4.33 Million	262,300 Added 743.06%	297,600 $3.87 Million
Q4 2020 Feb 16, 2021	SELL	$2.92 - $4.84 $299,884 - $497,068	-102,700 Reduced 74.42%	35,300 $119,000
Q3 2020 Nov 16, 2020	SELL	$3.03 - $5.48 $18,483 - $33,428	-6,100 Reduced 4.23%	138,000 $540,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $450,075 - $786,675	127,500 Added 768.07%	144,100 $764,000
Q1 2020 May 15, 2020	SELL	$3.53 - $12.21 $143,318 - $495,726	-40,600 Reduced 70.98%	16,600 $69,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $859,236 - $1.29 Million	-74,200 Reduced 56.47%	57,200 $696,000
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $516,061 - $737,177	37,100 Added 39.34%	131,400 $2.05 Million
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $291,499 - $626,756	-22,100 Reduced 18.99%	94,300 $1.38 Million
Q1 2019 May 15, 2019	BUY	$12.43 - $28.91 $1.45 Million - $3.37 Million	116,400 New	116,400 $2.63 Million

Others Institutions Holding EOLS

# of Institutions

163

Shares Held

49.1M

Call Options Held

453K

Put Options Held

14K

Perceptive Advisors LLC New York, NY

5.75M
Shares

$97.9 Million
1.81% of portfolio
Tang Capital Management LLC San Diego, CA

4.85M
Shares

$82.5 Million
6.42% of portfolio
Black Rock Inc. New York, NY

4.01M
Shares

$68.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.99M
Shares

$50.8 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.91M
Shares

$49.5 Million
2.11% of portfolio

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $955M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account